Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a partnership with Everlywell, a digital health ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine. Diagnosing kidney cancer ...

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

Conventional diagnostic tools, such as ultrasound, MRI, PET, CT scans, and scintigraphy, often identify cancer only at later stages. These methods can be expensive, expose patients to radiation, and ...